Trial of Cannabidiol for Drug‐Resistant Seizures in the Dravet Syndrome

@article{Devinsky2017TrialOC,
  title={Trial of Cannabidiol for Drug‐Resistant Seizures in the Dravet Syndrome},
  author={O. Devinsky and Helen J. Cross and L. Laux and E. Marsh and I. Miller and R. Nabbout and I. Scheffer and E. Thiele and S. Wright},
  journal={The New England Journal of Medicine},
  year={2017},
  volume={376},
  pages={2011–2020}
}
  • O. Devinsky, Helen J. Cross, +6 authors S. Wright
  • Published 2017
  • Medicine
  • The New England Journal of Medicine
  • BACKGROUND The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug‐resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug‐resistant seizures in the Dravet syndrome. METHODS In this double‐blind, placebo‐controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug‐resistant seizures to receive either cannabidiol oral solution at a dose of 20 mg per kilogram of body weight per day… CONTINUE READING
    284 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The overarching objective of the proposed project is to test the clinical efficacy of CBD in the treatment of post-traumatic stress disorder using a rigorous double-blind randomized… Expand
    ConditionsPost Traumatic Stress Disorder
    InterventionDrug, Other
    INTERVENTIONAL CLINICAL TRIAL
    The overarching objective of the proposed project is to test the relative clinical efficacy of CBD isolate, full-spectrum CBD oil, and placebo in in reducing COVID-Induced stress… Expand
    ConditionsAlcohol Abuse, Anger, Anxiety Depression, (+3 more)
    InterventionDietary Supplement
    INTERVENTIONAL CLINICAL TRIAL
    The clinical trial "A Prospective Single-Center Single-Arm Clinical Trial on Cognitive Effect of Cannabidiol (CBD-OS®) on Dravet syndrome and Lennox-Gastaut Syndrome" is a single-group… Expand
    ConditionsDravet Syndrome, Lennox Gastaut Syndrome
    InterventionDrug
    INTERVENTIONAL CLINICAL TRIAL
    The initial goal is to ascertain the pharmacokinetic (PK) profile of CBD (cannabidiol) after a single dose of CBDE (cannabidiol extract), although the plan is to extend these studies to… Expand
    ConditionsEpilepsy
    InterventionDrug
    Epilepsy: Cannabidiol reduces seizure frequency in Dravet syndrome
    • C. Ridler
    • Medicine
    • Nature Reviews Neurology
    • 2017
    • 6
    Treatment Strategies for Dravet Syndrome
    • 24

    References

    SHOWING 1-10 OF 17 REFERENCES
    Mortality in Dravet syndrome
    • 95
    Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
    • 221
    • PDF
    Sudden Unexpected Death in Epilepsy
    • M. Nei, R. Hays
    • Medicine
    • Current neurology and neuroscience reports
    • 2010
    • 305
    Toward drugs derived from cannabis
    • 93
    • PDF
    : a mul - ticentre open - label trial
    • 2015